Career transitions and practice patterns among international medical graduates in oncology workforce: A US nationwide analysis.

J Jiazhang Xing (Sinai Hospital of Baltimore, Baltimore, MD) Q Qian Wang Y Yixin Tang (UT Southwestern Medical Center, Dallas, TX) C Chuan Angel Lu (UT Southwestern Medical Center, Dallas, TX) F Fangyuan Chen (School of Materials Science and Engineering, National Institute of New Materials Research) A Arya Mariam Roy L Lei Deng K Karun Neupane (2H. Lee Moffitt Cancer Center, Tampa, United States) F Fatemeh Ardeshir Larijani (Winship Cancer Institute, Emory School of Medicine, Atlanta, GA) T Tanios S. Bekaii-Saab C Charu Aggarwal A Alfred Ian Lee (Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT) T Taofeek K. Owonikoko (University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore) M Mariana Chavez Mac Gregor (The University of Texas MD Anderson Cancer Center, Houston, TX) Z Ziad Bakouny (Memorial Sloan Kettering Cancer Center) S Shipra Gandhi (Winship Cancer Institute of Emory University, Atlanta, GA) N Nazli Dizman (The University of Texas MD Anderson Cancer Center, Houston, TX) T Toni K. Choueiri (Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA) S Stuthi Perimbeti (Penn State Cancer Institute, Hershey, PA) C Changchuan Jiang

Abstract

9009 Background: International Medical Graduates (IMGs) are a vital component of the US oncology workforce, representing nearly half of practicing medical oncologists. However, systemic barriers may influence their career trajectories differently. Understanding these challenges is essential for addressing workforce disparities and optimizing cancer care delivery across diverse geographic regions. Methods: We conducted a cross-sectional study of 13,497 medical oncologists using the 2024 Dec CMS Provider Dataset linked with the 2023 Rural-Urban Continuum Codes (RUCC). Medical oncologists were identified by their self-reported primary specialties, including Hematology/Oncology, Medical Oncology, and Hematopoietic Cell Transplant. Physicians were categorized by graduation origin (based on their self-reported medical school), career stage (early: 0–10 years, mid: 11–30 years, late: >30 years post-medical school graduation). The primary outcomes included practice at Main Campus of NCI Designated Cancer Centers (as an indicator of academic practice) and the geographical location of their practice (Metro, Non-Metro, Mixed). We employed chi-squared tests for statistical comparisons and performed stratified analyses by career stage to evaluate transition patterns over time. Results: 6920 IMGs constituted 48.7% of the oncology workforce, with similar gender distributions between IMG and non-IMG oncologists (37.9% vs 36.5% female, p=0.068). Notably, early career oncologists were less likely to be IMGs (IMG vs non-IMGs: 8.2% vs 12.5%, p<0.001). Compared to Non-IMGs, IMG oncologists are less likely to practice at main campuses of NCI Center (19.9% vs. 27.7%, p<0.001), especially as their career advances (all p<0.01). (Table). IMGs had higher representation in non-metropolitan areas than non-IMGs (11.4% vs 9.1%, p<0.001), particularly in late-career stages (14.7% vs 12.3%, p=0.033), indicating their unique role in serving underserved regions. (Table). Conclusions: Our findings reveal that, IMGs are less likely to practice at main campuses of NCI-Cancer Center than their non-IMG colleagues. Meanwhile, IMG oncologists are disproportionately serving rural communities. Supporting IMG pathways in oncology is critical to ensure a balanced cancer care delivery across the United States. Practice setting distribution and academic affiliation among international medical graduates (IMGs) and US graduates (USGs) by career stage. IMG (N=6,577) Non-IMG (N=6,920) IMG (N=6,577) Non-IMG (N=6,920) NCI Center Other NCI Center Other Metro Non-Metro/Mixed Metro Non-Metro/Mixed Total 19.9% 80.1% 27.7% 72.3% 88.6% 11.4% 90.9% 9.1% Career Stage Early (0-10y) 29.1% 70.9% 36.1% 63.9% 91.1% 8.9% 95.4% 4.6% Mid (11-30y) 21.3% 78.7% 28.8% 71.2% 90.1% 9.9% 91.6% 8.4% Senior (30+y) 15.0% 85.0% 22.0% 78.0% 85.3% 14.7% 87.7% 12.3%

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 9009-9009
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

J

Jiazhang Xing

Sinai Hospital of Baltimore, Baltimore, MD

Q

Qian Wang

Y

Yixin Tang

UT Southwestern Medical Center, Dallas, TX

C

Chuan Angel Lu

UT Southwestern Medical Center, Dallas, TX

F

Fangyuan Chen

School of Materials Science and Engineering, National Institute of New Materials Research

A

Arya Mariam Roy

L

Lei Deng

K

Karun Neupane

2H. Lee Moffitt Cancer Center, Tampa, United States

F

Fatemeh Ardeshir Larijani

Winship Cancer Institute, Emory School of Medicine, Atlanta, GA

T

Tanios S. Bekaii-Saab

C

Charu Aggarwal

A

Alfred Ian Lee

Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT

T

Taofeek K. Owonikoko

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore

M

Mariana Chavez Mac Gregor

The University of Texas MD Anderson Cancer Center, Houston, TX

Z

Ziad Bakouny

Memorial Sloan Kettering Cancer Center

S

Shipra Gandhi

Winship Cancer Institute of Emory University, Atlanta, GA

N

Nazli Dizman

The University of Texas MD Anderson Cancer Center, Houston, TX

T

Toni K. Choueiri

Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

S

Stuthi Perimbeti

Penn State Cancer Institute, Hershey, PA

C

Changchuan Jiang